Holen Sie sich die Stockscreener-App
24.20
6.56%
1.49
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Tango Therapeutics president, R&D Adam Crystal sells $573k in shares - Investing.com
Tango Therapeutics (TNGX) R&D president exercises 27K options, sells 27K shares - Stock Titan
Tango Therapeutics (TNGX) CFO receives 40,000 RSUs and 240,000 options - Stock Titan
Tango Therapeutics (TNGX) price target increased by 11.68% to 24.38 - MSN
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Invus and Avicenna disclose passive stakes in Tango Therapeutics (NASDAQ: TNGX) - Stock Titan
Jefferies raises Tango Therapeutics stock price target on RAS deal - Investing.com
Stifel reiterates Tango Therapeutics stock Buy rating at $15 - Investing.com
Tango Therapeutics (TNGX) price target increased by 32.09% to 20.06 - MSN
Tango Therapeutics (TNGX) director receives RSU and option grants as board compensation - Stock Titan
Tango Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
TNGX (NASDAQ: TNGX) affiliate files to sell 65,460 shares after option exercise - Stock Titan
New CFO and hire get 512,900 Tango stock awards under Nasdaq rule - Stock Titan
Here's Why We're Not Too Worried About Tango Therapeutics' (NASDAQ:TNGX) Cash Burn Situation - Moomoo
The Nasdaq Biotechnology Index closed down more than 1.2%. Among its constituent stocks, Tango Therapeutics fell by 12.25%, Personalis dropped 8.36%, PTC Therapeutics decreased by 8.13%, Foghorn slid 8.12%, and Erasca declined 7.98%. - Bitget
Tango Therapeutics (NASDAQ:TNGX) Trading Down 9.7%Here's What Happened - MarketBeat
Tango Therapeutics is the best performing healthcare stock in March - MSN
How New C-Suite Hires At Tango Therapeutics (TNGX) Have Changed Its Investment Story - simplywall.st
Stifel raises Tango Therapeutics stock price target on drug combo potential - Investing.com UK
Stifel raises Tango Therapeutics stock price target on drug combo potential By Investing.com - Investing.com South Africa
Stifel Nicolaus Issues Positive Forecast for Tango Therapeutics (NASDAQ:TNGX) Stock Price - MarketBeat
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
[Form 3] Tango Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CFO Matthew Gall (TNGX) files Form 3 with no reported trades - Stock Titan
TNGX Financials: Income Statement, Balance Sheet & Cash Flow | Tango Therapeutics Inc - Stock Titan
Tango Therapeutics stock hits all-time high at 27.16 USD By Investing.com - Investing.com Australia
Tango Therapeutics stock hits all-time high at 27.16 USD - Investing.com
354,192 Shares in Tango Therapeutics, Inc. $TNGX Bought by Mass General Brigham Inc - MarketBeat
Stifel reiterates Tango Therapeutics stock rating on combo potential By Investing.com - Investing.com Australia
Stifel reiterates Tango Therapeutics stock rating on combo potential - Investing.com
HBS1L degradation inducers named in Tango Therapeutics patent - BioWorld News
Is Tango Therapeutics’ New Leadership Bench Reframing Its R&D Ambitions or Its Risk Profile (TNGX)? - simplywall.st
Tango Therapeutics (TNGX) Stock Stop Loss (Eye on Rally) 2026-04-18Stock Ideas - UBND thành phố Hải Phòng
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):